We are live on ! Find out more
SA

Sicart Associates Portfolio holdings

AUM $389M
1-Year Est. Return 42.46%
This Fund
S&P 500
This Quarter Est. Return
+4.62%
1 Year Est. Return
+42.46%
3 Year Est. Return
+89.06%
5 Year Est. Return
+118.65%
10 Year Est. Return
–
AUM
$420M
AUM Growth
+$41.9M
Cap. Flow
+$32.2M
Cap. Flow %
7.66%
Top 10 Hldgs %
44.29%
Holding
115
New
10
Increased
24
Reduced
25
Closed
–

Top Buys

Rank Stock Value
1
CPB icon
Campbell Soup
CPB
+$7.41M
2
GH icon
Guardant Health
GH
+$5.45M
3
PFE icon
Pfizer
PFE
+$4.57M
4
MRK icon
Merck
MRK
+$4.31M
5
KO icon
Coca-Cola
KO
+$4.15M

Top Sells

Rank Stock Value
1
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$2.43M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$336K
3
CARS icon
Cars.com
CARS
+$299K
4
ALB icon
Albemarle
ALB
+$298K
5
WFC icon
Wells Fargo
WFC
+$261K

Sector Composition

Rank Sector Weight
1 Healthcare 22.83%
2 Consumer Staples 14.42%
3 Materials 10.35%
4 Communication Services 10.06%
5 Technology 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WPM icon
51
Wheaton Precious Metals
WPM
$49.5B
$939K 0.22%
21,300
-1,550
-7% -$69K
SLV icon
52
iShares Silver Trust
SLV
$28B
$911K 0.22%
37,618
– –
SKM icon
53
SK Telecom
SKM
$12.1B
$894K 0.21%
17,269
+1,821
+12% +$92.7K
PRU icon
54
Prudential Financial
PRU
$42.4B
$859K 0.2%
8,380
– –
FNV icon
55
Franco-Nevada
FNV
$41.1B
$797K 0.19%
5,495
-950
-15% -$137K
XOM icon
56
ExxonMobil
XOM
$644B
$741K 0.18%
11,754
– –
CB icon
57
Chubb
CB
$135B
$736K 0.18%
4,605
+25
+0.5% +$4.14K
KTOS icon
58
Kratos Defense & Security Solutions
KTOS
$8.74B
$722K 0.17%
25,325
+300
+1% +$7.93K
BNY
59
Bank of New York Mellon
BNY
$106B
$706K 0.17%
13,785
– –
ROK icon
60
Rockwell Automation
ROK
$53.4B
$686K 0.16%
2,400
+50
+2% +$13.5K
MMM icon
61
3M
MMM
$90.9B
$661K 0.16%
3,983
– –
CCJ icon
62
Cameco
CCJ
$37.6B
$649K 0.15%
33,825
+4,600
+16% +$86.8K
EMR icon
63
Emerson Electric
EMR
$83.9B
$648K 0.15%
6,732
– –
DD icon
64
DuPont de Nemours
DD
$18.5B
$638K 0.15%
6,562
– –
PLTR icon
65
Palantir
PLTR
$295B
$595K 0.14%
+22,564
New +$522K
REGN icon
66
Regeneron Pharmaceuticals
REGN
$78.5B
$594K 0.14%
1,063
– –
PAAS icon
67
Pan American Silver
PAAS
$18.2B
$580K 0.14%
20,300
-1,925
-9% -$62K
LVS icon
68
Las Vegas Sands
LVS
$31.7B
$540K 0.13%
10,250
-2,250
-18% -$130K
DOW icon
69
Dow Inc
DOW
$21.9B
$521K 0.12%
8,237
– –
DNMR
70
DELISTED
Danimer Scientific, Inc.
DNMR
$519K 0.12%
+518
New +$516K
ADSK icon
71
Autodesk
ADSK
$49.5B
$496K 0.12%
1,700
– –
CTXS
72
DELISTED
Citrix Systems Inc
CTXS
$496K 0.12%
4,230
-30
-0.7% -$3.74K
ABT icon
73
Abbott
ABT
$183B
$474K 0.11%
4,089
– –
AI icon
74
C3.ai
AI
$1.43B
$474K 0.11%
+7,585
New +$471K
CDE icon
75
Coeur Mining
CDE
$15.4B
$470K 0.11%
52,925
-1,250
-2% -$12.1K
1 2
3
4 5

Similar funds

AIM
Aigen Investment Management New York $389M AUM 16.77% 1-Year Est. Return
WCM
Winthrop Capital Management Carmel, Indiana $389M AUM 16.76% 1-Year Est. Return
HP
Hilltop Partners Mishawaka, Indiana $390M AUM 16.72% 1-Year Est. Return
P8IP
Pier 88 Investment Partners San Francisco, California $390M AUM 10.13% 1-Year Est. Return
PFPGI
Patriot Financial Partners GP II Radnor, Pennsylvania $388M AUM
PG
Prostatis Group Hanover, Maryland $391M AUM 20.37% 1-Year Est. Return
S
SimplyRich Carlsbad, California $391M AUM 24.42% 1-Year Est. Return
LHC
Little House Capital Braintree, Massachusetts $387M AUM 27.85% 1-Year Est. Return

Sicart Associates's Q2 2021 Portfolio in Review

As of Q2 2021, Sicart Associates held 115 positions worth $420M, up 11% from $378M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Sicart Associates deployed $32.2M of net new capital in Q2 2021, opening 10 new positions and adding to 24 existing holdings. Its largest new stake was Campbell Soup: 153,970 shares worth $7.02M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Consumer Staples and Materials.

On the sell side, the largest reduction was iPath Series B S&P 500 VIX Short-Term Futures ETN, an estimated $2.43M trimmed.

  • Sicart Associates's largest Q2 2021 buy was Campbell Soup: 153,970 shares worth $7.02M.
  • Sicart Associates added most to Pfizer in Q2 2021, an estimated $4.57M increase.
  • Sicart Associates's biggest Q2 2021 reduction was iPath Series B S&P 500 VIX Short-Term Futures ETN, cutting an estimated $2.43M.
  • Sicart Associates's ten largest holdings make up 44% of its $420M portfolio in Q2 2021.
  • Sicart Associates opened 10 new positions and closed 0 in Q2 2021.
  • Sicart Associates's portfolio value rose 11% quarter-over-quarter to $420M.

Based on Sicart Associates's 13F filing for Q2 2021, filed 23 Jul 2021.